DC Healthcare Holdings Bhd posted a profit after tax (PAT) of RM0.43 million for the nine months ended Sept 30, 2025 (9M25), marking a sharp turnaround from a loss after tax of RM16.77 million in 9M24. The return to profitability was underpinned by strong revenue growth and improved operational efficiency.
Revenue for 9M25 rose 64.1% to RM64.22 million, mainly driven by the Group’s aesthetic segment, which contributed RM54.89 million — signalling sustained demand for non-invasive and minimally invasive treatments. Enhanced operating leverage, disciplined cost management and improved service realisation further boosted profitability.
For the third quarter ended Sept 30, 2025 (3Q25), DC Healthcare achieved a PAT of RM2.3 million, compared to a loss of RM2.15 million in 3Q24. Revenue increased 62.7% to RM25.72 million, while gross profit doubled to RM14.44 million, supported by higher treatment redemptions and stronger cash collections.
Managing Director Dr Chong Tze Sheng said the Group’s return to profitability highlights the resilience of its operating model and the effectiveness of its ongoing efficiency initiatives.
“Strong demand for our aesthetic services continues to support our growth trajectory,” he added.
Dr Chong also shared that the Group is progressing with strategic initiatives to sustain momentum, including integrating its brands — Dr Chong Clinic, Dr Chong Slimming and NewB Premium Skincare — expanding its skincare product range, and adopting artificial intelligence-assisted skin analysis to enhance treatment outcomes.
Additionally, the Group’s recent RM8 million property acquisition in Bandar Kinrara, Puchong, is expected to lower long-term operating costs and provide greater operational flexibility.
He emphasised that with these measures, DC Healthcare is well-positioned to continue its recovery and capture growth opportunities in Malaysia’s expanding medical aesthetic market.
2025-11-26T16:00:00Z